Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 12, 2019

Determining Risk of Recurrence in Triple-Negative Breast Cancer

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.

May 13, 2019

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies

Apr 23, 2019

Air Pollution Poses Risks for Childhood Cancer Survivors

Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and published in the International Journal of Environmental Research and Public Health.

Mar 14, 2019

Huntsman Cancer Institute applauds the Utah State Legislature for raising the age of sale for tobacco products to 21

Huntsman Cancer Institute (HCI) at the University of Utah applauds the bold actions taken by the Utah State Legislature this week in addressing tobacco-related health issues. The state’s approval of a policy that incrementally increases the age from 19 to 21 for the sale and use of tobacco products, e-cigarettes, and vaping devices—a policy called Tobacco 21—is a step that will ensure Utah remains a national leader in health by reducing tobacco-related illnesses and protecting youth from nicotine addiction.

Mar 13, 2019

How Barbershops Will Play a Role in Reducing Colorectal Cancer Disparities among African-American Men

African-American men are more likely to die from colon cancer than any other racial group. That fact led a researcher at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) to begin a long-term project to understand why.

Mar 04, 2019

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.